MYC and cancer: The reversibility of deregulated Myc has also been observed in cancers where the deactivation of ectopic Myc in pancreatic and lung cancers leads to the complete regression of tumorigenesis and restoration of the normal tissue architecture (Kortlever et al., 2017; Sodir et al., 2020).